NCT00004380View on ClinicalTrials.gov

Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

December 31, 1991

Study Completion Date

December 31, 1997

Conditions
Systemic Sclerosis
Interventions
DRUG

relaxin

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

Stanford University

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004380 - Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis | Biotech Hunter | Biotech Hunter